Infectious diseases Events | Infectious Disease Conferences | Meetings |USA | Europe | 2017| Middle East | Asia Pacific | Allied Academies

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Infectious diseases and therapeutics
- Worldwide infectious-diseases 2017

About

Allied Academic Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies.  This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

Welcome Message

Allied Academies Conferences invites all the participants from all over the world to attend “2nd International Conference on Worldwide Infectious Diseases” during November 06-08, 2017 in New Orleans, Louisiana, USA which includes prompt keynote presentations, special sessions, workshops, symposiums, oral talks, poster presentations and exhibitions. 

Worldwide Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of microbiology especially clinical and diagnostic microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health.

Who should attend?

ü  Microbiologists

ü  Bacteriologists

ü  Virologists

ü  Parasitologists

ü  Mycologists

ü  Pathologists

ü  Pharmacists

ü  Epidemiologists

ü  Health Care Professionals

ü  Infectious Diseases Specialists

ü  Infection Prevention and Infection Control Specialists

Why to attend?

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Targeted Audience

ü  Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments

ü  Infectious Diseases Researchers, Scientists, Faculties, Students

ü  Infectious Diseases Associations and Societies

ü  Medical Colleges

ü  Pharmaceutical Companies and Industries

ü  Medical Devices Manufacturing Companies

ü  Drug Manufacturing Companies and Industries

ü  Laboratory Technicians and Diagnostic Companies

ü  Business Entrepreneurs and Industrialists

ü  Training Institutes

ü  Software Developing Companies

ü  Data Management Companies

Benefits:

ü  Acknowledged modified works will be distributed in specified journals with DOI.

ü  Ecumenical systems administration: In exchanging and trading Conceptions.

ü   Organizing with specialists in your field.

ü  Master Forums.

ü   Best Poster Awards.

ü  Best Start-Up Awards.

ü  Preconference and Conference Workshops.

ü  Symposiums on Latest Research.

We welcome everyone to participate in New Orleans, USA to advance "Worldwide Infectious Diseases” 

 

Sessions/Tracks

Track 1:infectious diseases

Directly or indirectly viruses,fungi,microorganisms,bacteria  or parasites are major causes of infectious diseases.some popularly known infectious diseases are dengue fever,chikungunya,chickenpox,leprosy,measles. With proper diagnosis and treatment infectious diseases can be controlled and cured.

 

Track 2:ebola and zika viral infections

Ebola hemorrhagic simply known as ebola is viral fever to humans .between two days to three weeks singns and symptoms start with fever,headaches,muscular pain and sour throat.on multiplications of virus patient suffer from vomitings , diarrhea and rashs followed by decreased functioning of kidneys and liver.zika fever is a infectious disease caused by zika virus.mother to child during pregnancy can cause microcephaly.

 

Track 3:infection and immune system

Set of tissues functioning together to oppose a infection is called as immune system. Different type of disease agents such as viruses,bacteria and parasites can be detected by immune system. It can also identify difference between foregin cells and cells within the body. When immune system detects foregin cells it creates antibodies to fight the intruders.

 

Track 4:animal and plant infectious diseases

Viruses that effect animal and plant,diseases caused do to effection is called as infection diseases in plant and animals.like all other viruses, plant viruses are obligate intracellular parasites that do not have the molecular machinery to replicate without a host.each has their own specific range of viruses that often infect only that species.

 

Track 5:pediatric infectious diseases

Pediatrics is a branch which deals with children. The diseases which effect children are called pediatrics infectious diseases.candida albicans infection ,candida parapsilosis infection,cytomegalovirus infection,diphtheria are some of the diseases effect infants.

 

Track 6:blood stream infections

Catheter-related bloodstream infection (crbsi) is defined as the presence of bacteremia originating from an intravenous catheter. It is one of the most frequent, lethal, and costly complications of central venous catheterization and also the most common cause of nosocomial bacteremia. Intravascular catheters are integral to the modern practices and are inserted in critically-ill patients for the administration of fluids, blood products, medication, nutritional solutions, and for hemodynamic monitoring.

 

Track 7:neuro and urinary infections

Infection caused to urinary tract is urinary tract infectious disease. When is effects upper parts its called kidney infection and when infected lower part is called bladder infection. Neurological infections occur when these viruses and organisms invade the nervous system.encephalitis,meningitis are major neurological infections.

 

Track 8:tuberculosis, hepatitis, malaria

The above diseases are infectious diseases caused do to viruses or bacteria or parasities.malaria is a mosquito-borne infectious disease,hepatitis is a group of diseases characterized by inflammation of the liver.tuberculosis (tb) is an infectious disease caused by the bacterium mycobacterium tuberculosis

 

Track 9:vaccination for infectious diseasesbiological

Preparation which gives active acquired immunity to a particular disease is called as vaccine.vaccination is the administration of antigenic material (a vaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen.some of the vaccination are inactivated, attenuated,toxoid,subunit,valence etc..

 

Track 10:infectious diseases prevention, control and cure

Infectious diseases like the flu, drug-resistant diseases like tuberculosis, and well-known viruses like hiv/aids are still present in our population. Policies and regulations impact prevention and control by observing immunization rates, regulating antibiotics and other drugs and controlling transmission.

 

Track 11:diagnosis and treatment of infectious diseases

Diagnosis is identifying a diseases.some of the tests are laboratory and imaging. Treatment is medical care given to a patient for an illness or injury.some of the treatment are done by giving antibiotics,antivirals,antifungals,anti-parasities and some alternative medicines like vitamins , zinc , garlic.

 

Track 12:sexually transmitted infections

Sexually transmitted infections are also known as venereal diseases (vd). Symptoms and signs of disease may include vaginal discharge, penile discharge, ulcers on or around the genitals, and pelvic pain.some vaccinations may also decrease the risk of certain infections including hepatitis b and some types of hpv.

 

Track 13:recent advances  in emerging infectious diseases

Studies of these emerging infections reveal the evolutionary properties of pathogenic microorganisms and the dynamic relationships between microorganisms, their hosts and the environment.

Market Analysis

Infectious Diseases Market Report mainly focuses on:

Assessment of the current trend and state of Infectious Diseases on a global basis.

Identification of the key factors for demand of advanced and new diagnostic and pharmaceutical products.


Estimation of current and future market for diagnostics, vaccines and pharmaceutical products.


Estimation of the current supply and demand situation worldwide depending on the region and type of disease.

The Infectious Diseases market is expected to reach $18,156.2 million by 2019 from $12,422.8 million in 2014 at a CAGR of 7.9% from 2014 to 2019.

The global market for Infectious Diseases diagnostics, vaccines and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012.  There is a continuous market growth and the overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.

The global market for Infectious Diseases treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014 and the largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.

Worldwide deaths due to Infectious Diseases are observed in the following order: Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4million).

The global market for Infectious Disease diagnostics, vaccines and pharmaceutical treatment products reached $108.4 billion in 2015, $126.2 billion in 2016 and expected to reach $183.2 billion in 2021 with a compound annual growth rate (CAGR) of 7.7% from 2016 to 2021.
Pharmaceutical treatments made fastest growth in the Infectious Diseases market totalling $65.4 billion in 2015 and $78.3 billion in 2016. The market segment should grow at a CAGR of 8.8% leading to a projected total of $119.3 billion by 2021.
The vaccine market for Infectious Diseases totalled $25.2 billion in 2015, $28.5 billion in 2016 and $39.7 billion in 2021 at a CAGR of 6.8%.

Factors responsible for Infectious Diseases global market growth:

High prevalence rate of Infectious Diseases

Increased demand for rapid diagnostic techniques


Increase in government funding are driving market growth


Raising healthcare costs


Complex regulatory framework

Infectious Diseases global market is divided into instruments and analyzers, consumables (assays and reagents) and software & services. Consumables accounted for the largest share 70% of the global IDD market in 2014.

Depending on the applications Infectious Diseases market is sub divided into Hepatitis B, Hepatitis C, Acquired Immunodeficiency Syndrome (AIDS), Tuberculosis (TB), Chlamydia Trachomatis and Gonorrhea, Human Papillomavirus (HPV), Methicillin-resistant Staphylococcus aureus (MRSA) and others.

Depending on the technology the segment is divided into traditional and molecular diagnostics. Traditional diagnostics include immunodiagnostics, microscopy and biochemical characterization and the molecular diagnostics include Polymerase Chain Reaction (PCR), INAAT (Isothermal Nucleic Acid Amplification Test), Hybridization, DNA Sequencing & NGS, microarrays and others (electrophoresis, mass spectrometry, and flow cytometry). This increased growth in Infectious Diseases market is mainly due to the specificity and increased efficiency of these tests.

Depending on the end users the market is divided into hospital laboratories, reference labs, physician’s office labs, academics and others like blood banks, local public health laboratories, home health agencies, nursing homes, point of care and self-testing. Of all these hospital laboratories played an important role in market growth of Infectious Diseases in 2014.

Infectious Diseases are also the frequent target of novel technology applications including PCR-alternative molecular amplification methods, next-generation sequencing (NGS), microarrays and mass spectrometry. Advancements in instrument automated analysis and microfluidics have allowed for the proliferation of Infectious diseases testing across settings and institutions from traditional sites such as reference labs through physician office laboratories (pols) and mobile clinics in the developing world. 

Major players observed in the Infectious Diseases market are Roche Diagnostics (Switzerland), biomérieux SA (Craponne, France), Thermo Fischer Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Bio-Rad Laboratories (U.S.) and Becton, Dickinson & Company (U.S.).

Major Companies includes:
Alere ,Beckman Coulter 
Becton, Dickinson & Co. (BD) 
biomérieux ,Bio-Rad Laboratories 
Cepheid ,Chembio Diagnostics Systems 
diasorin ,Grifols ,Hologic 
Meridian Bioscience 
orasure Technologies 
Ortho-Clinical Diagnostics 
Qiagen,Quidel Corporation 
Roche Diagnostics 
Siemens Healthcare Diagnostics 
Thermo Fisher Scientific  
Trinity Biotech   

Societies and Associations related to Infectious Diseases:

Healthcare Infection Society

European Society for Pediatric Infectious Diseases

European Society of Clinical Microbiology and Infectious Diseases

Infection Prevention Society

British Society for Immunology

British Infection Association

British Infection Association

European Society for pediatric Infectious diseases

Health care Infection Society

Worldwide societies for infectious diseases is about 150

Universities related to Infectious Diseases:

University of Cambridge

Kings College of London

London School of Hygiene and Tropical Medicine

Imperial College London

UCL Institute of Epidemiology and Health care

University of Sheffeild

Pediatric Infectious Diseases Society:

Columbia University

University of Maryland

Swedish Institute for Infectious Disease Control

Uppsala University

University of Gothenburg

University of Otago

Oslo University

University of Pittsburgh

Emory Health Sciences

Queensland University of Technology

University of Liverpool

University of Colorado Denver

Infectious Diseases Society of America

Medical College of Georgia at Georgia Regents   University


Why in new Orleans:

The National Hansen's Disease (Leprosy) Clinical Center in Baton Rouge, Louisiana is the only facility in the United States devoted to diagnosis, treatment, and research concerning Hansen’s Disease (HD).

The Tulane National Primate Research Center conducts research in non-human primates. Areas of focus include HIV/SIV, Lyme disease, tuberculosis, malaria and a Regional Biosafety Lab, where the focus is on the development of treatments, vaccines and diagnostics for emerging infectious diseases that occur naturally, such as Severe Acute Respiratory Syndrome (SARS) and against biological agents that have the potential for misuse for terrorism

 

 

To Collaborate Scientific Professionals around the World

Conference Date November 6-8, 2017
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Venue
&
Hospitality


Join The Discussion
Copyright © 2017-2018 Allied Academies, All Rights Reserved.